This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Netherlands, New Zealand, Poland, Singapore, United Kingdom, United States
The drug MIRVASO contains one active pharmaceutical ingredient (API):
|
1
Brimonidine
UNII 4S9CL2DY2H - BRIMONIDINE TARTRATE
|
|
Brimonidine is an alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenoceptor than the alpha1-adrenoreceptor. This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated with human retinal xenografts. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| MIRVASO Gel | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D11AX21 | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1642463, 1642474, 1642485, 1816130, 1849653, 1849664 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 113904006 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 524981 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68293613 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 241118 |
| Country: HK | Department of Health Drug Office | Identifier(s): 63413 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 13127 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1075473, 1075474, 1075475, 1082360 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 114375 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 17396 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100322657 |
| Country: SG | Health Sciences Authority | Identifier(s): 14828P |
| Country: US | FDA, National Drug Code | Identifier(s): 0299-5980 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
